⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYMR News
Kymera Therapeutics, Inc. Common Stock
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
globenewswire.com
KYMR
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
globenewswire.com
KYMR
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
globenewswire.com
KYMR